Literature DB >> 12556016

Proliferation of type II pneumocytes in the lung biopsy specimens reflecting alveolar damage.

T Honda1, H Ota, Y Yamazaki, A Yoshizawa, K Fujimoto, S Sone.   

Abstract

Proliferation of type II pneumocytes may be the most sensitive pathological indicator of alveolitis, and the density of type II pneumocytes reflecting the severity of the recent alveolar damage. Twenty-nine patients were divided into three groups by the severity of ground-glass opacities on the CT scans; the severe (acute), the moderate (subacute) and the mild (chronic) groups. We compared the density of type II pneumocytes in the transbronchial lung biopsy specimens and cell analysis of bronchoalveolar lavage (BAL) fluid with the ground-glass opacities. Clinical and laboratory findings and BAL fluid analysis also corresponded well with this grouping. Type II pneumocytes were selectively stained with an antibody against Thomsen-Friedenreich and the density of the type II pneumocytes was expressed as the number per 1 mm alveolar septal length. The densities of the type II pneumocytes in the severe, the moderate, the mild, and the control groups were 21.2+/-1.1, 14.4+/-7.2, 11.0+/-3.3 and 7.5+/-0.9/mm, respectively. There were significant differences between the acute group and the other three groups, and between the control and chronic groups. The density of type II pneumocytes is a useful index for evaluating alveolar damage even in mild alveolitis.

Entities:  

Mesh:

Year:  2003        PMID: 12556016     DOI: 10.1053/rmed.2002.1408

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  2 in total

1.  Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease.

Authors:  Marco Confalonieri; Emanuele Buratti; Gabriele Grassi; Rossana Bussani; Marco Chilosi; Rossella Farra; Michela Abrami; Cristiana Stuani; Francesco Salton; Miriam Ficial; Paola Confalonieri; Lorenzo Zandonà; Maurizio Romano
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

2.  Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats.

Authors:  Neama M Albanawany; Doaa M Samy; Noha Zahran; Riham M El-Moslemany; Shefaa Mf Elsawy; Maha W Abou Nazel
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.